IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAMI OWERA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1659399624
CMS profile
302546
Location
PENSACOLA, FL

General Payments · PY2018–2024

$112,609.89

  • Reported across 404 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$16,459.14

62 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology FL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,100.00 3
Consulting Fee $3,615.00 2
Honoraria $1,470.00 1
Food and Beverage $1,333.82 54
Travel and Lodging $923.30 1
Education $17.02 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BeiGene USA, Inc. $12,166.99 7
Acerta Pharma LLC $1,749.01 5
Exelixis Inc. $1,470.00 1
NOVARTIS PHARMACEUTICALS CORPORATION $159.50 7
Celgene Corporation $124.07 6
Janssen Biotech, Inc. $105.16 5
EISAI INC. $96.86 4
Regeneron Healthcare Solutions, Inc. $69.37 3
Takeda Pharmaceuticals U.S.A., Inc. $64.62 2
Lilly USA, LLC $50.49 2
Mirati Therapeutics, Inc. $46.03 1
Genentech USA, Inc. $43.74 2
Merck Sharp & Dohme Corporation $34.86 2
Ipsen Biopharmaceuticals, Inc $26.34 1
Daiichi Sankyo Inc. $25.47 1
Sumitomo Pharma America, Inc. $22.83 1
Gilead Sciences, Inc. $22.55 1
Tempus AI, Inc $20.90 1
Blueprint Medicines Corporation $19.68 1
Adaptive Biotechnologies Corporation $17.67 1
PFIZER INC. $17.35 1
Genmab U.S., Inc. $16.68 1
E.R. Squibb & Sons, L.L.C. $16.10 1
Bayer HealthCare Pharmaceuticals Inc. $15.92 1
Novocure Inc. $15.24 1
Astellas Pharma US Inc $15.10 1
SpringWorks Therapeutics, Inc. $13.42 1
Coherus Biosciences Inc. $13.19 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $20,248.14 76
PY2019 $27,189.78 91
PY2020 $9,623.51 22
PY2021 $2,637.01 31
PY2022 $11,995.29 57
PY2023 $24,457.02 65
PY2024 $16,459.14 62

Payment records · PY2024 (62)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Adaptive Biotechnologies Corporation $17.67 06/27/2024 Food and Beverage Undisputed 01/23/2026 1150259866 CMS
Astellas Pharma US Inc $15.10 05/30/2024 Food and Beverage Undisputed 01/23/2026 1139342880 CMS
AstraZeneca Pharmaceuticals LP $22.21 01/03/2024 Food and Beverage Undisputed 01/23/2026 1104397809 CMS
AstraZeneca Pharmaceuticals LP $1,665.00 03/05/2024 Consulting Fee Undisputed 01/23/2026 1104593374 CMS
AstraZeneca Pharmaceuticals LP $21.92 10/31/2024 Food and Beverage Undisputed 01/23/2026 1105888731 CMS
AstraZeneca Pharmaceuticals LP $18.38 11/05/2024 Food and Beverage Undisputed 01/23/2026 1104247957 CMS
AstraZeneca Pharmaceuticals LP $21.50 12/03/2024 Food and Beverage Undisputed 01/23/2026 1105479291 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.92 04/03/2024 Food and Beverage Undisputed 01/23/2026 1086168794 CMS
BeiGene USA, Inc. $1,300.00 02/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1120855722 CMS
BeiGene USA, Inc. $923.30 04/04/2024 Travel and Lodging Undisputed 01/23/2026 1120855724 CMS
BeiGene USA, Inc. $84.43 04/04/2024 Food and Beverage Undisputed 01/23/2026 1120855726 CMS
BeiGene USA, Inc. $3,900.00 04/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1120855728 CMS
BeiGene USA, Inc. $3,900.00 06/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1120855718 CMS
BeiGene USA, Inc. $109.26 06/24/2024 Food and Beverage Undisputed 01/23/2026 1120855720 CMS
BeiGene USA, Inc. $1,950.00 12/06/2024 Consulting Fee Undisputed 01/23/2026 1120855716 CMS
Blueprint Medicines Corporation $19.68 05/22/2024 Food and Beverage Undisputed 01/23/2026 1147443897 CMS
Celgene Corporation $17.39 01/17/2024 Food and Beverage Undisputed 01/23/2026 1101193641 CMS
Celgene Corporation $16.00 02/13/2024 Food and Beverage Undisputed 01/23/2026 1101193647 CMS
Celgene Corporation $18.21 05/08/2024 Food and Beverage Undisputed 01/23/2026 1101193655 CMS
Celgene Corporation $29.88 07/30/2024 Food and Beverage Undisputed 01/23/2026 1101193659 CMS
Celgene Corporation $18.59 08/20/2024 Food and Beverage Undisputed 01/23/2026 1101193663 CMS
Celgene Corporation $24.00 10/31/2024 Food and Beverage Undisputed 01/23/2026 1101193665 CMS
Coherus Biosciences Inc. $13.19 12/18/2024 Food and Beverage Undisputed 01/23/2026 1147277118 CMS
Daiichi Sankyo Inc. $25.47 09/03/2024 Food and Beverage Undisputed 01/23/2026 1089465332 CMS
E.R. Squibb & Sons, L.L.C. $16.10 04/10/2024 Food and Beverage Undisputed 01/23/2026 1101836225 CMS
Eisai Inc. $13.15 03/05/2024 Food and Beverage Undisputed 01/23/2026 1110774897 CMS
Eisai Inc. $28.71 08/13/2024 Food and Beverage Undisputed 01/23/2026 1110774899 CMS
Eisai Inc. $30.19 10/24/2024 Food and Beverage Undisputed 01/23/2026 1110774901 CMS
Eisai Inc. $24.81 11/19/2024 Food and Beverage Undisputed 01/23/2026 1110774903 CMS
Exelixis Inc. $1,470.00 04/11/2024 Honoraria Undisputed 01/23/2026 1138564268 CMS
Genentech USA, Inc. $20.34 03/26/2024 Food and Beverage Undisputed 01/23/2026 1133092814 CMS
Genentech USA, Inc. $23.40 10/08/2024 Food and Beverage Undisputed 01/23/2026 1133092810 CMS
Genmab U.S., Inc. $16.68 05/30/2024 Food and Beverage Undisputed 01/23/2026 1126831010 CMS
Gilead Sciences, Inc. $22.55 01/29/2024 Food and Beverage Undisputed 01/23/2026 1133797031 CMS
Ipsen Biopharmaceuticals, Inc $26.34 09/25/2024 Food and Beverage Undisputed 01/23/2026 1091950145 CMS
Janssen Biotech, Inc. $20.06 01/23/2024 Food and Beverage Undisputed 01/23/2026 1078476739 CMS
Janssen Biotech, Inc. $21.73 01/24/2024 Food and Beverage Undisputed 01/23/2026 1078477649 CMS
Janssen Biotech, Inc. $18.04 02/07/2024 Food and Beverage Undisputed 01/23/2026 1078476450 CMS
Janssen Biotech, Inc. $25.12 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078477605 CMS
Janssen Biotech, Inc. $20.21 10/16/2024 Food and Beverage Undisputed 01/23/2026 1078477501 CMS
Lilly USA, LLC $25.22 02/18/2024 Food and Beverage Undisputed 01/23/2026 1135351961 CMS
Lilly USA, LLC $25.27 07/22/2024 Food and Beverage Undisputed 01/23/2026 1135331221 CMS
Merck Sharp & Dohme LLC $16.16 04/02/2024 Food and Beverage Undisputed 01/23/2026 1141940795 CMS
Merck Sharp & Dohme LLC $18.70 10/01/2024 Food and Beverage Undisputed 01/23/2026 1141754580 CMS
Mirati Therapeutics, Inc. $46.03 04/24/2024 Food and Beverage Undisputed 01/23/2026 1117178181 CMS
Novartis Pharmaceuticals Corporation $19.58 01/31/2024 Food and Beverage Undisputed 01/23/2026 1087293549 CMS
Novartis Pharmaceuticals Corporation $21.02 04/04/2024 Food and Beverage Undisputed 01/23/2026 1087293551 CMS
Novartis Pharmaceuticals Corporation $30.21 05/07/2024 Food and Beverage Undisputed 01/23/2026 1087293567 CMS
Novartis Pharmaceuticals Corporation $16.66 08/06/2024 Food and Beverage Undisputed 01/23/2026 1087293571 CMS
Novartis Pharmaceuticals Corporation $19.68 08/14/2024 Food and Beverage Undisputed 01/23/2026 1087293573 CMS
Novartis Pharmaceuticals Corporation $18.34 08/22/2024 Food and Beverage Undisputed 01/23/2026 1087293581 CMS
Novartis Pharmaceuticals Corporation $34.01 08/28/2024 Food and Beverage Undisputed 01/23/2026 1087293579 CMS
Novocure Inc. $15.24 04/09/2024 Food and Beverage Undisputed 01/23/2026 1123338211 CMS
PFIZER INC. $17.35 11/07/2024 Food and Beverage Undisputed 01/23/2026 1131391516 CMS
Regeneron Healthcare Solutions, Inc. $17.02 08/08/2024 Education Undisputed 01/23/2026 1114129096 CMS
Regeneron Healthcare Solutions, Inc. $28.69 09/10/2024 Food and Beverage Undisputed 01/23/2026 1114129098 CMS
Regeneron Healthcare Solutions, Inc. $23.66 12/11/2024 Food and Beverage Undisputed 01/23/2026 1114129100 CMS
SpringWorks Therapeutics, Inc. $13.42 09/26/2024 Food and Beverage Undisputed 01/23/2026 1085806847 CMS
Sumitomo Pharma America, Inc. $22.83 11/21/2024 Food and Beverage Undisputed 01/23/2026 1148899621 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.98 08/21/2024 Food and Beverage Undisputed 01/23/2026 1144964486 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.64 11/13/2024 Food and Beverage Undisputed 01/23/2026 1144964488 CMS
Tempus AI, Inc $20.90 05/13/2024 Food and Beverage Undisputed 01/23/2026 1150171333 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.